{"id":633738,"date":"2025-10-02T13:50:09","date_gmt":"2025-10-02T17:50:09","guid":{"rendered":"https:\/\/www.singlecare.com\/blog\/?p=633738"},"modified":"2026-01-28T14:07:31","modified_gmt":"2026-01-28T19:07:31","slug":"does-medicaid-cover-zepbound","status":"publish","type":"post","link":"https:\/\/www.singlecare.com\/blog\/does-medicaid-cover-zepbound\/","title":{"rendered":"Does Medicaid cover Zepbound?"},"content":{"rendered":"

Zepbound<\/span><\/a> (generic name: tirzepatide) is a weekly injectable medication approved by the U.S. Food and Drug Administration (FDA) for weight loss management and the treatment of moderate to severe obstructive sleep apnea (OSA) in individuals with obesity. The dual GIP and GLP-1 receptor agonist, manufactured by Eli Lilly, is not uniformly covered by Medicaid; however, some states may provide coverage for the weight loss drug for obesity treatment if deemed medically necessary.<\/span><\/p>\n

Does Medicaid cover Zepbound?<\/span><\/h2>\n

According to Annie DePasquale, MD, a board-certified family medicine physician and founder and CEO of Collaborating Docs in Arlington, Virginia, coverage for Zepbound varies by state and plan. \u201cMany Medicaid programs now cover at least some anti-obesity medications\u2014but rules vary widely,\u201d she explains. \u201cSome states\/plans include Zepbound (often with prior authorization); others still exclude weight-loss drugs or limit coverage to certain clinical scenarios.\u201d<\/span><\/p>\n

Zepbound\u2019s manufacturer states that some Medicaid plans may cover the prescription medication only for obstructive sleep apnea, but not for chronic weight management or weight loss.<\/span><\/p>\n

Under the Medicaid Drug Rebate Program (MDRP), state Medicaid programs must cover almost all FDA-approved drugs for medically accepted indications\u2014but weight loss medications like Zepbound, Ozempic, Wegovy, and others are included in a small group of drugs that can be excluded from coverage. Although the FDA has approved six drugs for weight management (IMCIVREE, Saxenda, Wegovy, Qsymia, Xenical, and Zepbound), state Medicaid programs aren\u2019t required to provide coverage for this medical indication.<\/span><\/p>\n

You can visit the drug manufacturer\u2019s insurance coverage and savings page, scroll down to \u201cI have insurance through Medicaid,\u201d and then use the locator to find your state program\u2019s drug list (PDL) or formulary to see if they cover Zepbound.\u00a0<\/span><\/p>\n

Obstructive sleep apnea (OSA)<\/span><\/h3>\n

As mentioned, most Medicaid programs will cover Zepbound for obstructive sleep apnea (OSA). In 2024, the FDA <\/span>approved the use of Zepbound for OSA<\/span><\/a> in adults with obesity. Because of this, while Medicaid won\u2019t directly cover the medication for weight loss, many state programs will cover beneficiaries diagnosed with the sleep condition who may also be obese.\u00a0<\/span><\/p>\n

For example, in <\/span>Alabama Medicaid\u2019s preferred drug list<\/span><\/a>, Zepbound is preferred for patients with OSA with obesity indication, but not for weight loss directly.<\/span><\/p>\n

Dr. DePasquale also lists the following as situations where Medicaid may not cover Zepbound:<\/span><\/p>\n